P/E at 65.86 vs Industry's 66.45: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Close to Industry Norms

Apollo Hospitals Enterprise Ltd. trades at a P/E of 65.86, marginally below the hospital industry average of 66.45. This near parity suggests that the market values the company’s earnings in line with its peers, reflecting neither a significant premium nor discount. Given the company’s large-cap status with a market capitalisation of ₹1,28,861.25 crores, this valuation level indicates investor confidence in its earnings stability and growth prospects relative to the sector. However, the premium is modest enough to invite scrutiny on whether the current price fully factors in recent operational performance or sector headwinds. Previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in the valuation premium alongside other metrics.

Performance Across Timeframes: A Tale of Contrasts

Examining returns over multiple periods reveals a stock that has outperformed the broader market consistently over the medium to long term. The one-year return of 22.03% dwarfs the Sensex’s negative 2.37%, while the year-to-date gain of 27.26% contrasts sharply with the benchmark’s 7.66% decline. Over three years, the stock has surged 79.46%, more than tripling the Sensex’s 20.61% gain, and over five years, it has more than doubled with a 119.02% return compared to the Sensex’s 46.20%. The ten-year performance is even more striking, with a 566.87% increase versus the Sensex’s 184.10% rise.

However, the short-term momentum is less robust. Over the past week, the stock has gained 1.35%, underperforming the Sensex’s 2.41% advance. Similarly, the one-month return of 0.73% trails the benchmark’s 1.19%. Interestingly, the three-month return of 17.32% significantly outpaces the Sensex’s 2.31%, indicating a strong rebound in the recent quarter. This divergence between short-term underperformance and medium-term strength — is this a recovery or a dead-cat bounce? — the moving average configuration provides the clearest answer.

Moving Average Configuration: Bullish Across All Horizons

The technical picture for Apollo Hospitals Enterprise Ltd. is notably positive. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a strong upward momentum across short, medium, and long-term horizons. This comprehensive bullish configuration is relatively rare and suggests sustained buying interest and price strength. The stock is also trading just 0.01% below its 52-week high of ₹9,099.95, underscoring its resilience and ability to maintain levels near peak valuations.

Such a configuration often indicates a trend continuation rather than a temporary rally, especially when supported by strong fundamentals and sector tailwinds. The stock’s outperformance relative to the sector on the day (+0.6%) further reinforces this positive technical stance. Is this momentum sustainable, or is the stock due for a consolidation phase?

Sector Context: Hospital Industry Performance

The hospital sector has experienced mixed results recently, with a blend of positive, flat, and negative performances across constituent stocks. The industry P/E of 66.45 reflects a relatively high valuation, consistent with the sector’s growth orientation and defensive characteristics. Apollo Hospitals Enterprise Ltd. sits comfortably within this valuation band, neither stretched nor undervalued relative to peers.

Sector results have been buoyed by increased healthcare demand and expansion in specialised services, but challenges such as regulatory changes and cost pressures persist. The stock’s ability to maintain a premium valuation close to the sector average while delivering strong multi-year returns highlights its competitive positioning. Should investors in Apollo Hospitals hold, buy more, or reconsider?

Rating Context: Previously Hold, Now Reassessed

MarketsMOJO had previously rated Apollo Hospitals Enterprise Ltd. as Hold. The rating was updated on 11 May 2026, reflecting a reassessment of the company’s fundamentals, valuation, and technical indicators. While the current rating is not disclosed, the data-driven approach behind the change considers the stock’s strong relative performance, near-industry valuation, and robust moving average configuration.

This reassessment aligns with the company’s consistent outperformance over multiple timeframes and its technical strength, suggesting a positive shift in the underlying assessment framework. What is the current rating for Apollo Hospitals Enterprise Ltd. following this reassessment?

Conclusion: Data Paints a Picture of Steady Strength

The comprehensive data analysis of Apollo Hospitals Enterprise Ltd. reveals a stock trading at a valuation closely aligned with its hospital sector peers, supported by strong multi-year returns and a bullish technical setup. The divergence between short-term underperformance and medium-term strength suggests a nuanced momentum profile, with recent gains signalling renewed investor interest.

The stock’s position above all major moving averages and proximity to its 52-week high reinforce the view of sustained price strength. Meanwhile, the sector’s mixed performance and the company’s reassessed rating add further layers to the investment narrative. Should investors consider the current rating as a signal to adjust their holdings in Apollo Hospitals Enterprise Ltd.?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →